NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
191 hedge funds and large institutions have $2.99B invested in NPS PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 77 increasing their positions, 61 reducing their positions, and 37 closing their positions.
30% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 37
26% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 61
16% more call options, than puts
Call options by funds: $31.4M | Put options by funds: $27.1M
5% more funds holding
Funds holding: 182 → 191 (+9)
3% more capital invested
Capital invested by funds: $2.89B → $2.99B (+$94.5M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$46.5M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$44.3M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$30.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.9M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$28.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$43.1M |
| 2 |
Millennium Management
New York
|
-$26.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.1M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$22.3M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$20.4M |
NPSP Hedge Fund Activity: Q4 2013 in Review
191 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2013, worth a combined $2.99B — up 3.3% from $2.89B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new NPSP positions and 37 closed out — a net gain of 11 holders — while 77 added to existing stakes and 61 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $46.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $43.1M sold.
- 191 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2013, up from 182 in Q3 2013.
- Funds reported $2.99B of NPS PHARMACEUTICALS INC stock for Q4 2013, up 3.3% quarter-over-quarter.
- 48 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2013 and 37 closed out, a net change of +11 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q4 2013 was AllianceBernstein, an estimated $46.5M added.
- The largest NPS PHARMACEUTICALS INC seller in Q4 2013 was Consonance Capital Management, an estimated $43.1M sold.
Based on aggregated 13F filings for Q4 2013.